BridgeMD
New treatment option for Bone Sarcoma
Official title Preoperative Immunonutrition in Patients With Bone and Soft Tissue Sarcomas
ClinicalTrials.gov ID: NCT07609329
What this study is testing
- What it's testing
- This study will evaluate whether a short nutritional intervention before surgery can improve recovery in patients with bone and soft tissue sarcomas. Patients with these tumors often have a higher risk of poor nutrition and loss of muscle mass.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Participants must meet all of the following criteria:
- Adult patients aged 18 years or older.
- Histologically confirmed bone sarcoma or soft tissue sarcoma.
- Localized or oligometastatic disease.
- Indicated for planned orthopedic tumor resection.
You likely can't join if
- Participants will be excluded if any of the following criteria are present:
- Indication for urgent surgery.
- Disseminated disease with more than five metastases.
- Ongoing parenteral nutrition before study enrollment.
- Inability to receive oral intake.
- Severe hepatic failure.
See the full eligibility criteria
- Participants must meet all of the following criteria:
- Adult patients aged 18 years or older.
- Histologically confirmed bone sarcoma or soft tissue sarcoma.
- Localized or oligometastatic disease.
- Indicated for planned orthopedic tumor resection.
- Preoperative interval allowing administration of the nutritional intervention for at least 7 days, with 14 days preferred when clinically feasible.
- Ability to receive oral nutritional supplementation.
- Signed informed consent for participation in the study.
- Participants will be excluded if any of the following criteria are present:
- Indication for urgent surgery.
- Disseminated disease with more than five metastases.
- Ongoing parenteral nutrition before study enrollment.
- Inability to receive oral intake.
- Severe hepatic failure.
- Severe renal failure.
The study team makes the final eligibility decision.
Where it's taking place
- Brno, Czechia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brno, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.